AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4575-4580

  Steinberg, Gregory R ^a,d   Smith, Angela C ^b   Van Denderen, Bryce J W ^a   Chen, Zhiping ^a   Murthy, Sid ^a   Campbell, Duncan J ^a   Heigenhauser, G J F ^c   Dyck, David J ^b   Kemp, Bruce E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF GUELPH   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA2; LEPTIN; MESSENGER RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME SUBUNIT; ESTERIFICATION; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FEMALE; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; LIPID STORAGE; MUSCLE BIOPSY; NUCLEOTIDE SEQUENCE; OBESITY; OXIDATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECTUS ABDOMINIS MUSCLE; SKELETAL MUSCLE;

ACETYL-COA CARBOXYLASE; ADENYLATE KINASE; ADULT; AMINOIMIDAZOLE CARBOXAMIDE; DOWN-REGULATION; FATTY ACIDS; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN SUBUNITS; RIBONUCLEOTIDES; RNA, MESSENGER;

RECTUS;

EID: 4544287365     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0308     Document Type: Article

References (34)

1. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ 2002 Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol 283:E187-E192
2. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JFC, Luiken JJFP, Heigenhauser GJF, Dyck DJ 2004 Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18:1144-1146
3. Kelley DE, Goodpaster B, Wing RR, Simoneau J-A 1999 Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-E1141
4. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA 2003 Skeletal muscle lipid metabolism with obesity. Am J Physiol 284:E741-E747
5. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, Gupta A, Adams JJ, Kastsis F, Van Denderen B, Jenning IG, Iseli T, Michell BJ, Witters LA 2003 AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31:162-168
6. Muoio D, Seefeld K, Witters LA, Coleman RA 1999 AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338:783-791
7. Luiken JJ, Coort SLM, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JFC 2003 Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP activated protein kinase signaling. Diabetes 52:1627-1634
8. Zhou M, Lin B-Z, Coughlin S, Vallega G, Pilch PF 2000 UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. Am J Physiol 279:E622-E629
9. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO 2000 Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88:2219-2226
10. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, Shulman GI 2002 AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 99:15983-15987
11. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343
12. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
13. Muoio DM, Dohm GL, Fiedorek FTJ, Tapscott EB, Coleman RA 1997 Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46:1360-1363
14. Merrill GF, Kurth EJ, Hardie DG, Winder WW 1997 AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273:E1107-E1112
15. Steinberg GR, Dyck DJ 2000 Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol 279:E1374-E1382
16. Watt MJ, Holmes AG, Steinberg GR, Mesa JL, Kemp BE, Febbraio MA 2004 Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity in human skeletal muscle. Am J Physiol 287:E120-E127
17. Bernocchi P, Ceconi C, Cargnoni A, Pedersini P, Curello S, Ferrari R 1994 Extraction and assay of creatine phosphate, purine, and pyridine nucleotides in cardiac tissue by reversed-phase high-performance liquid chromatography. Anal Biochem 222:374-379
18. Chen Z-P, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE 2000 AMPK signaling in contracting human skeletal muscle: acyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol 279:E1202-E1206
19. Stephens TJ, Chen Z-P, Canny BJ, Michell BJ, Kemp BE, McConell GK 2002 Progressive increase in human skeletal muscle AMPKα2 activity and ACC phosphorylation during exercise. Am J Physiol 282:E688-E694
20. Chen Z, Heierhorst J, Mann RJ, Mitchelhill KI, Michell BJ, Witters LA, Lynch GS, Kemp BE, Stapleton D 1999 Expression of the AMP-activated protein kinase β1 and β2 subunits in skeletal muscle. FEBS Lett 460:343-348
21. Hamilton SR, O'Donnell Jr JB, Hammet A, Stapleton D, Habinowski SA, Means AR, Kemp BE, Witters LA 2002 AMP-activated protein kinase kinase: detection with recombinant AMPK α1 subunit. Biochem Biophys Res Commun 293:892-898
22. Pearson RB, Mitchelhill K, Kemp BE 1993 In: Hardie DG, ed. Protein phosphorylation: a practical approach. Oxford, UK: Oxford University Press; 265-291
23. Hojlund K, Mustard KJ, Staehr P, Hardie DG, Beck-Nielsen H, Richter EA, Wojtaszewski JFP 2004 AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes. Am J Physiol Endocrinol Metab 286:E239-E244
24. Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O, Thorell A, Goodyear LJ 2001 AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50:921-927
25. Koistinen HA, Galuska D, Chibalin AV, Yang J, Zierath JR, Holman GD, Wallberg-Henriksson H 2003 5-Amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52:1066-1072
26. Aschenbach WG, Hirshman MF, Fujii N, Sakamoto K, Howlett KF, Goodyear LJ 2002 Effect of AICAR treatment on glycogen metabolism in skeletal muscle. Diabetes 51:567-573
27. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JFP 2003 Knockout of the α-2 but not α-1 5′AMP-activated protein kinase isoform abolishes AICAR but not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279:1070-1079
28. Buhl ES, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen SB, Pedersen O, Schmitz O, Lund S 2002 Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51:2199-2206
29. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ 2002 Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51:2074-2081
30. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI 2002 Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345-1350
31. Steinberg GR, Rush JWE, Dyck DJ 2003 AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am J Physiol 284:E648-E654
32. Steinberg GR, Bonen A, Dyck DJ 2002 Fatty acid oxidation and triacylglycerol hydrolysis are enhanced following chronic leptin treatment in rats. Am J Physiol 282:E593-E600
33. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A 2002 Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570-578
34. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kuschner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M 1999 Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568-1575